Two dose levels of once-weekly fosravuconazole versus daily itraconazole in combination with surgery in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial.

Autor: Fahal AH; Mycetoma Research Centre, University of Khartoum, Khartoum, Sudan. Electronic address: ahfahal@hotmail.com., Ahmed ES; Mycetoma Research Centre, University of Khartoum, Khartoum, Sudan., Bakhiet SM; Mycetoma Research Centre, University of Khartoum, Khartoum, Sudan; Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan., Bakhiet OE; Mycetoma Research Centre, University of Khartoum, Khartoum, Sudan., Fahal LA; Mycetoma Research Centre, University of Khartoum, Khartoum, Sudan., Mohamed AA; Mycetoma Research Centre, University of Khartoum, Khartoum, Sudan., Mohamedelamin ESW; Mycetoma Research Centre, University of Khartoum, Khartoum, Sudan; Department of Surgery, Faculty of Medicine, Alneelain University, Khartoum, Sudan., Bahar MEN; Mycetoma Research Centre, University of Khartoum, Khartoum, Sudan., Attalla HY; Mycetoma Research Centre, University of Khartoum, Khartoum, Sudan., Siddig EE; Mycetoma Research Centre, University of Khartoum, Khartoum, Sudan; Department of Medical Microbiology and Infectious Diseases, University Medical Center Rotterdam, Erasmus MC, Rotterdam, Netherlands., Mhmoud NA; Mycetoma Research Centre, University of Khartoum, Khartoum, Sudan., Musa AM; Mycetoma Research Centre, University of Khartoum, Khartoum, Sudan; Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan., van de Sande WWJ; Department of Medical Microbiology and Infectious Diseases, University Medical Center Rotterdam, Erasmus MC, Rotterdam, Netherlands., Scherrer B; Bruno Scherrer Conseil, Saint Arnoult en Yvelines, France., Oyieko P; Drugs for Neglected Diseases initiative (DNDi), Nairobi, Kenya., Egondi TW; Drugs for Neglected Diseases initiative (DNDi), Nairobi, Kenya., Onyango KO; Drugs for Neglected Diseases initiative (DNDi), Nairobi, Kenya., Hata K; Global Health Research Section, Eisai, Tsukuba, Japan., Chu WY; Department of Pharmacy, Uppsala University, Uppsala, Sweden., Dorlo TPC; Department of Pharmacy, Uppsala University, Uppsala, Sweden., Brüggemann RJ; Department of Pharmacy and Radboudumc-CWZ Center of Expertise in Mycology, Radboud University Medical Center, Nijmegen, Netherlands., Nyaoke BA; Drugs for Neglected Diseases initiative (DNDi), Nairobi, Kenya., Strub-Wourgaft N; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland., Zijlstra EE; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland.

Publikováno v: The Lancet. Infectious diseases [Lancet Infect Dis] 2024 Nov; Vol. 24 (11), pp. 1254-1265. Date of Electronic Publication: 2024 Aug 01.

Use of Aprotinin versus Tranexamic Acid in Cardiac Surgery Patients with High-Risk for Excessive Bleeding (APACHE) trial: a multicentre retrospective comparative non-randomized historical study.

Autor: Gallo E; Department of Cardiovascular Anaesthesia and Critical Care, CHU Bordeaux, France., Gaudard P; Department of Anaesthesia and Critical Care, Arnaud de Villeneuve Hospital, Montpellier, France., Provenchère S; Department of Anaesthesia and Critical Care, Bichat Claude Bernard Hospital, Paris, France., Souab F; Department of Anaesthesia and Critical Care, Hôpital Laennec, CHU Nantes, France., Schwab A; Department of Anaesthesia and Critical Care, Hospices Civils de Lyon, France., Bedague D; Department of Anaesthesia and Critical Care, Grenoble-Alpes University Hospital, France., de La Barre H; Department of Anaesthesia and Critical Care, Hôpital Européen Georges Pompidou, Paris, France., de Tymowski C; Department of Anaesthesia and Critical Care, Bichat Claude Bernard Hospital, Paris, France., Saadi L; Department of Anaesthesia and Critical Care, Arnaud de Villeneuve Hospital, Montpellier, France., Rozec B; Department of Anaesthesia and Critical Care, Hôpital Laennec, CHU Nantes, France., Cholley B; Department of Anaesthesia and Critical Care, Hôpital Européen Georges Pompidou, Paris, France., Scherrer B; Bruno Scherrer Conseil, Saint Arnoult en Yvelines, France., Fellahi JL; Department of Anaesthesia and Critical Care, Hospices Civils de Lyon, France., Ouattara A; Department of Cardiovascular Anaesthesia and Critical Care, CHU Bordeaux, France.

Publikováno v: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery [Eur J Cardiothorac Surg] 2024 Feb 01; Vol. 65 (2).

Yttria-stabilized zirconia thin films by pulsed laser deposition: Microstructural and compositional control

Autor: Heiroth, S., Lippert, T., Wokaun, A., Döbeli, M., Rupp, J.L.M., Scherrer, B., Gauckler, L.J.

Publikováno v: In Journal of the European Ceramic Society 2010 30(2):489-495

Sodium Oxybate for Alcohol Dependence: A Network Meta-Regression Analysis Considering Population Severity at Baseline and Treatment Duration.

Autor: Guiraud J; Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Department of Psychiatry, Amsterdam Neuroscience, Meibergdreef 5, 1105AZ Amsterdam, The Netherlands.; Vergio, 31 rue Fernand Pelloutier, 92110 Clichy, France., Addolorato G; Internal Medicine and Alcohol Related Disease Unit, Department of Medical and Surgical Sciences, Columbus-Gemelli Hospital, Fondazione Policlinico Universitario A. Gemelli IRCCS, Catholic University of Rome, Rome, 00168, Italy.; CEMAD Digestive Disease Center, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Catholic University of Rome, Rome, 00168, Italy., Aubin HJ; French Institute of Health and Medical Research (Inserm), Centre de Recherche en Epidémiologie et Santé des Populations (CESP), Universite Paris-Saclay, 94807, Villejuif, France.; Addiction Research and Treatment Center, Paul Brousse Hospital, Paris-Sud University, 94804, Villejuif, France., Bachelot S; D&A Pharma, 7 rue d'Aguesseau, 75008 Paris, France., Batel P; Addiction Unit of Charente, Camille Claudel Hospital, 16400 La Couronne, France., de Bejczy A; Section of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, 41328, Gothenburg, Sweden., Benyamina A; Addiction Research and Treatment Center, Paul Brousse Hospital, Paris-Sud University, 94804, Villejuif, France., Caputo F; Department of Internal Medicine, SS. Annunziata Hospital, University of Ferrara, 44042, Cento (Ferrara), Italy.; Centre for the Study and Treatment of Alcohol-Related Diseases, Department of Translational Medicine, University of Ferrara, 44042, Cento (Ferrara), Italy., Couderc M; Petry Medical Consulting, 92150, Suresnes, France., Dematteis M; Grenoble Alpes University, Faculty of Medicine and Grenoble-Alpes University Hospital, Department of Pharmacology and Addiction Medicine, 38043 Grenoble, France., Goudriaan AE; Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Department of Psychiatry, Amsterdam Neuroscience, Meibergdreef 5, 1105AZ Amsterdam, The Netherlands.; Arkin, Dept. of Research and Quality of Care, Amsterdam Public Health Research Institute, 1033 NN Amsterdam, The Netherlands., Gual A; Emeritus Researcher, GRAC (Addictions Research Group), IDIBAPS, 08036, Barcelona, Spain., Lecoustey S; D&A Pharma, 7 rue d'Aguesseau, 75008 Paris, France., Lesch OM; University Clinic of Psychiatry and Psychotherapy, Department of Social Psychiatry, Medical University of Vienna, 1090, Vienna, Austria., Maremmani I; Department of Neurosciences, Santa Chiara University Hospital, University of Pisa, 56100, Pisa, Italy., Nutt DJ; Centre for Neuropsychopharmacology, Imperial College London, W12 0NN, London, United Kingdom., Paille F; Department of Addiction Treatment, University Hospital, 54500, Vandoeuvre-lès-Nancy, France., Perney P; Department of Addiction Medicine, CHU Nîmes; French Institute of Health and Medical Research (Inserm), Centre de Recherche en Epidémiologie et Santé des Populations (CESP), Universite Paris-Saclay, Villejuif, 94807, France., Rehm J; Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, M5S2S1, Canada; Dalla Lana School of Public Health & Department of Psychiatry, University of Toronto, Toronto, Ontario, M5T1P8, Canada; Clinical Psychology & Psychotherapy Technical University Dresden, 01187, Dresden, Germany; Department of International Health Projects, Institute for Leadership and Health Management, I.M. Sechenov First Moscow State Medical University, Moscow, 119991, Russian Federation., Rolland B; SUAL, HCL, CH Le Vinatier; Univ Lyon; UCBL; INSERM U1028; CNRS UMR5292, Centre de Recherche en Neuroscience de Lyon (CRNL), F-69678, Bron, France., Scherrer B; Bruno Scherrer Conseil, 78730, Saint Arnoult en Yvelines, France., Simon N; Aix Marseille Univ, APHM, INSERM, IRD, SESSTIM, Hop Sainte Marguerite, Department of Clinical Pharmacology, CAP-TV, 13005, Marseille, France., Söderpalm B; Section of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, 41328, Gothenburg, Sweden., Somaini L; Addiction Treatment Center, Local Health Unit, ASL Biella, 13875, Biella, Italy., Sommer WH; Institute of Psychopharmacology, Central Institute of Mental Health, Heidelberg University, D-68159, Mannheim, Germany.; Bethanian Hospital for Psychiatry, Psychosomatics and Psychotherapy, 17489, Greifswald, Germany., Spanagel R; Institute of Psychopharmacology, Central Institute of Mental Health, Heidelberg University, D-68159, Mannheim, Germany., Walter H; University Clinic of Psychiatry and Psychotherapy, Department of Social Psychiatry, Medical University of Vienna, 1090, Vienna, Austria., van den Brink W; Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Department of Psychiatry, Amsterdam Neuroscience, Meibergdreef 5, 1105AZ Amsterdam, The Netherlands.

Publikováno v: Alcohol and alcoholism (Oxford, Oxfordshire) [Alcohol Alcohol] 2023 Mar 10; Vol. 58 (2), pp. 125-133.

Sodium oxybate for the maintenance of abstinence in alcohol-dependent patients: An international, multicenter, randomized, double-blind, placebo-controlled trial.

Autor: Guiraud J; Department of Psychiatry, Amsterdam Neuroscience, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; D&A Pharma, Paris, France., Addolorato G; Alcohol Use Disorder and Alcohol Related Disease Unit, Department of Internal Medicine and Gastroenterology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.; Internal Medicine Unit, Columbus-Gemelli Hospital, Department of Internal Medicine and Gastroenterology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Antonelli M; Internal Medicine Unit, Columbus-Gemelli Hospital, Department of Internal Medicine and Gastroenterology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Aubin HJ; French Institute of Health and Medical Research (Inserm), Centre de Recherche en Epidémiologie et Santé des Populations (CESP), Universite Paris-Saclay, Villejuif, France.; Addiction Research and Treatment Center, Paul Brousse Hospital, Paris-Sud University, Villejuif, France., de Bejczy A; Section of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Goteborg, Sweden., Benyamina A; Addiction Research and Treatment Center, Paul Brousse Hospital, Paris-Sud University, Villejuif, France., Cacciaglia R; Laboratorio Farmaceutico CT, San Remo, Italy., Caputo F; Department of Internal Medicine, SS. Annunziata Hospital, Cento (Ferrara), University of Ferrara, Italy.; Centre for the Study and Treatment of Alcohol-Related Diseases, Department of Translational Medicine, University of Ferrara, Ferrara, Italy., Dematteis M; Department of Addiction Medicine, Grenoble-Alpes University Hospital, and Faculty of Medicine, Grenoble Alpes University, France., Ferrulli A; Department of Endocrinology, Nutrition and Metabolic Diseases, IRCCS MultiMedica, Milan, Italy.; Department of Biomedical Sciences for Health, University of Milan, Milan, Italy., Goudriaan AE; Department of Psychiatry, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.; Arkin, Department of Research and Quality of Care, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands., Gual A; Psychiatry Department, Neurosciences Institute, Hospital Clinic, IDIBAPS, Barcelona, Spain., Lesch OM; University Clinic of Psychiatry and Psychotherapy, Department of Social Psychiatry, Medical University of Vienna, Austria., Maremmani I; Santa Chiara University Hospital, University of Pisa, Italy., Mirijello A; Department of Medical Sciences, IRCCS Casa Sollievo della Sofferenza General Hospital, San Giovanni Rotondo (FG), Italy., Nutt DJ; Centre for Neuropsychopharmacology, Imperial College London, United Kingdom., Paille F; Department of Addiction Treatment, University Hospital, Vandoeuvre-lès-Nancy, France., Perney P; Addiction Medicine, CHU Nîmes, France., Poulnais R; D&A Pharma, Paris, France., Raffaillac Q; D&A Pharma, Paris, France., Rehm J; Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.; Department of Psychiatry, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Clinical Psychology & Psychotherapy Technical University Dresden, Dresden, Germany.; Department of International Health Projects, Institute for Leadership and Health Management, I.M. Sechenov First Moscow State Medical University, Moscow, Russia., Rolland B; SUAL, HCL, CH Le Vinatier; Univ Lyon; UCBL; INSERM U1028; CNRS UMR5292, Centre de Recherche en Neuroscience de Lyon (CRNL), Bron, France., Rotondo C; Centro di Riferimento Alcologico della Regione Lazio (CRARL), Dipartimento di Salute Mentale, Roma, Italy., Scherrer B; Bruno Scherrer Conseil, Saint Arnoult en Yvelines, France., Simon N; Aix Marseille Univ, APHM, INSERM, IRD, SESSTIM, Hop Sainte Marguerite, Department of Clinical Pharmacology, CAP-TV, Marseille, France., Skala K; Department of Child and Adolescent Psychiatry, Medical University of Vienna, Austria., Söderpalm B; Laboratorio Farmaceutico CT, San Remo, Italy., Somaini L; Addiction Treatment Center, Local Health Unit, ASL Biella, Italy., Sommer WH; Medical Faculty, Institute of Psychopharmacology, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany.; Institute of Psychopharmacology, Central Institute of Mental Health, Heidelberg University, Mannheim, Germany., Spanagel R; Institute of Psychopharmacology, Central Institute of Mental Health, Heidelberg University, Mannheim, Germany., Vassallo GA; Department of Internal Medicine, Barone Lombardo Hospital, Canicattì, Italy., Walter H; Santa Chiara University Hospital, University of Pisa, Italy., van den Brink W; Department of Psychiatry, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.

Publikováno v: Journal of psychopharmacology (Oxford, England) [J Psychopharmacol] 2022 Oct; Vol. 36 (10), pp. 1136-1145. Date of Electronic Publication: 2022 Jul 07.